Progressive ventricular dysfunction is not uncommon in patients with univentricular hearts as they age. In the acute setting vasoactive support can be employed, but is not always sufficient and patients occasionally require mechanical support. We report the successful implantation and subsequent challenges of a percutaneous Abiomed Impella ventricular assist device as a rescue therapy for a 15-year old-patient with Fontan circulation and severe ventricular dysfunction after cardiac arrest.
Get full access to this article
View all access options for this article.
References
1.
SchweigerMLortsAConwayJ. Mechanical circulatory support challenges in pediatric and (adult) congenital heart disease. Curr Opin Organ Transplant. 2018;23(3):301–307.
2.
HorneDConwayJRebeykaIMBuchholzH. Mechanical circulatory support in univentricular hearts: current management. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2015;18(1):17–24.
3.
WoodsRKGhanayemNSMitchellMEKindelSNieblerRA. Mechanical circulatory support of the Fontan patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017;20:20–27.
4.
MorrayBHDimasVVLimS. Circulatory support using the Impella device in Fontan patients with systemic ventricular dysfunction: a multicenter experience. Catheter Cardiovasc Interv. 2017;90(1):118–123.
5.
SibbaldMDžavíkV. Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device. Catheter Cardiovasc Interv. 2012;80(5):840–844.
6.
TanawuttiwatTChaparroSV. An unexpected cause of massive hemolysis in percutaneous left ventricular assist device. Cardiovasc Revasc Med. 2013;14(1):66–67.
